These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 9382757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR, Kiyono H.
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus.
    Mestecky J, Kutteh WH, Jackson S.
    AIDS Res Hum Retroviruses; 1994 Apr; 10 Suppl 2():S11-20. PubMed ID: 7865284
    [Abstract] [Full Text] [Related]

  • 7. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM.
    Am J Trop Med Hyg; 1994 Apr; 50(5 Suppl):42-54. PubMed ID: 8203723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The anatomy of mucosal immune responses.
    Garside P, Millington O, Smith KM.
    Ann N Y Acad Sci; 2004 Dec; 1029():9-15. PubMed ID: 15681738
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D, Ogra PL.
    Dev Biol Stand; 1998 Dec; 95():141-6. PubMed ID: 9855424
    [Abstract] [Full Text] [Related]

  • 13. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT, Pierce NF.
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [Abstract] [Full Text] [Related]

  • 14. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
    McGhee JR, Mestecky J.
    Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Humoral aspects of mucous membrane immunity--perspectives for the female genital tract].
    Briese V.
    Zentralbl Gynakol; 1986 Jun; 108(21):1282-8. PubMed ID: 3544610
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes.
    Di Martino C, Basset C, Ogier A, Charpilienne A, Poncet D, Kohli E.
    J Leukoc Biol; 2007 Oct; 82(4):821-8. PubMed ID: 17652448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting lymphocyte Peyer's patch adhesion molecule-1: a relay approach to gut immunization.
    McKenzie BS, Corbett AJ, Brady JL, Boyle JS, Rockman SP, Lew AM.
    Vaccine; 2005 May 25; 23(28):3668-78. PubMed ID: 15882527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.